Health Care & Life Sciences » Pharmaceuticals | Axsome Therapeutics Inc.

Axsome Therapeutics Inc.

Axsome Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.28
Market Cap
$900.57 M
Shares Outstanding
33.28 M
Public Float
20.74 M

Profile

Address
200 Broadway
New York New York 10038
United States
Employees -
Website http://www.axsome.com
Updated 07/08/2019
Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Financials

View All
Created with Highcharts 5.0.14Axsome Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.2 1662 1666 0006 00012 21012 21027 20127 20128 94328 94330 96530 965201320142015201620172018010k20k30k40k

Herriott Tabuteau
Chairman & Chief Executive Officer
Myrtle S. Potter
Independent Director